We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
Antibody Testing Resources
Use of FcRn Transgenic mice for drug discovery of therapeutic antibodies with Roche's Michael Otteneder, PhD

Use of FcRn Transgenic mice for drug discovery of therapeutic antibodies with Roche's Michael Otteneder, PhD

Published Date October 21, 2020

Previous Flipbook

Using Humanized In Vivo Models for Preclinical Antibody Development: A Case Study
Next Video

An Introduction to Human FcRn Mice - Greg Christianson

Other content in this Stream

almost 3 years ago
Preclinical Drug Development Fact Sheet

A glimpse at the wide range of platforms and services JAX offers to help move you from drug discovery to IND filing.

Read Flipbook
over 3 years ago
The Humanized FcRn Platform: An Essential Tool for Preclinical PK Assessment of Therapeutic Antibody Candidates

Greg Christianson, Study Director, In Vivo Services, The Jackson Laboratory speaks about the use of human FcRn transgenic mouse models to select antibody therapeutic candidates with optimum pharmacoki

Watch Video
over 3 years ago
JAX Antibody Development Summit - James Keck

Dr. James Keck, Senior Director, Innovation and Product Development, The Jackson Laboratory, presents De-risking Therapeutic Antibody Preclinical Drug Development: Simultaneous Assessment of Efficacy

Watch Video
almost 4 years ago
Using Humanized In Vivo Models for Preclinical Antibody Development: A Case Study

Read Flipbook
over 4 years ago
An Introduction to Human FcRn Mice - Greg Christianson

Watch Video
over 4 years ago
FcRn in Myeloid cells and the potential role of the IgG-hinge for recycling - Gestur Vidarsson, PhD

Watch Video
over 4 years ago
JAX Guide: Assessing Antibody Pharmacokinetics Using the JAX FcRn Platform

Read Flipbook
about 1 year ago
De-Risk Therapeutic Antibody Drug Development Using Humanized FcRn Platforms (Oct. 24, 2023)

In this webinar, we discuss the humanized FcRn platform, an effective tool that provides relevant PK data for candidate therapeutic antibodies and albumin-conjugated molecules.

Watch Video
over 4 years ago
JAX Live! Bispecific Antibody Testing

Watch Video
almost 5 years ago
FcRn: Preclinical Therapeutic Antibody and Albumin-Conjugate Evaluation

Read Flipbook

Return to Home

© The Jackson Laboratory